Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2013-06-17 | Currently, the members of the Audit Committee are Ronald Merriman, Chairman, Lawrence Best, Ronald Gelbman, Paul Black and Ellen Zane. |
| 2014-06-13 | Mr. Gelbman, 66, joined the Board of Directors in 2000 and serves on the Audit Committee and is Chairman of the Nominating and Governance Committee. |
| 2015-06-11 | Mr. Gelbman, 67, joined the Board of Directors in 2000 and serves on the Audit Committee and is Chairman of the Governance and Compliance Committee. |
| 2017-06-12 | Ronald G. Gelbman has been a member of the Haemonetics Board of Directors since 2000 and currently serves as Chair of the Governance & Compliance Committee and a member of the Audit Committee. He served as Interim Chief Executive Officer of Haemonetics from September 2015 until May 2016. Compensation for the Board of Directors in fiscal 2017 was $243,477 for Mr. Gelbman. |
| 2018-06-12 | Ronald G. Gelbman Retired Worldwide Chairman of the Pharmaceuticals, Health Systems and Diagnostics Group at Johnson & Johnson Age: 70 Mr. Gelbman joined our Board in 2000 and is Chairman of the Governance and Compliance Committee and a member of the Audit Committee. DIRECTOR COMPENSATION TABLE FOR FISCAL YEAR ENDED MARCH 31, 2018 Ronald G. Gelbman Fees Earned or Paid in Cash ($): 93,000 Stock Awards ($): 170,000 Total ($): 263,000 |
| 2019-06-12 | Ronald G. Gelbman Retired Worldwide Chair of Pharmaceuticals, Health Systems and Diagnostics Group at Johnson & Johnson. Age: 71. Mr. Gelbman joined our Board in 2000 and is Chair of the Governance and Compliance Committee and a member of the Audit Committee. Director Compensation Table for Fiscal Year Ended March 30, 2019 shows total compensation of $262,939. |
Data sourced from SEC filings. Last updated: 2025-08-30